Detail page

Knowledge Web

Person

Alfredo Ramírez (1976-)

Name	Alfredo Ramírez
Time	1976- (Date of birth and death)
Place	Deutschland
Academic degree	Dr. med. (Fachbereich Molekulare Humangenetik an der Univ. Bonn) (2004)
Variant	Alfredo Estanislao Ramírez-Zuñiga Alfredo Estanislao Ramírez Zuñiga Alfredo Estanislao Ramírez Zuñiga
Related	Neurogenetik (Thema)
Further information	Habil. Fach Neurogenetik an der Univ. Lübeck und 2014 an der Univ. Bonn
Record type	Person
GND-Identifier	129506117
Record ID	129506117
Involved in show all Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjects Neuroinflammation in Alzheimer disease X‐chromosome-wide association study for Alzheimer’s disease Assessing blood-brain barrier dysfunction and its association with Alzheimer’s pathology, cognitive impairment and neuroinflammation Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition Dementia with Lewy bodies: old and new knowledge – Part 1: clinical aspects and diagnostics = Demenz mit Lewy-Körpern: alte und neue Erkenntnisse – Teil 1: Klinik und Diagnostik Dementia with Lewy bodies: old and new knowledge—Part 2: treatment = Demenz mit Lewy-Körpern: alte und neue Erkenntnisse – Teil 2: Behandlung Epigenome-wide analysis identifies methylome profiles linked to obsessive-compulsive disorder, disease severity, and treatment response Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve Epigenome-wide analysis identifies methylome profiles linked to obsessive-compulsive disorder, disease severity, and treatment response Step by step: towards a better understanding of the genetic architecture of Alzheimer’s disease Brain Health Services: Erfassung des individuellen Demenzrisikos am Kölner Alzheimer Präventionszentrum Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2 Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers Genome-wide meta-analyses reveal novel loci for verbal short-term memory and learning Alzheimer’s Disease Plasma Biomarkers Distinguish Clinical Diagnostic Groups in Memory Clinic Patients The mind's ratio : How the balance between ω-6 and ω-3 fatty acids affects the risk of late-life dementia Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity Searching for the Holy Grail Will Need Biomarkers A rare heterozygous TREM2 coding variant identified in familial clustering of dementia affects an intrinsically disordered protein region and function of TREM2 PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer’s disease-related dysregulation Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study The BDNF Val66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer’s disease Cognitive behavioural therapy for the treatment of late life depression : : study protocol of a multicentre, randomized, observer-blinded, controlled trial (CBTlate) Genetik der Alzheimer-Krankheit Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE) Genetic estimators of DNA methylation provide insights into the molecular basis of polygenic traits Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease Novel genetic matching methods for handling population stratification in genome-wide association studies Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration Recessive dystonia-ataxia syndrome in a Turkish family caused by a COX20 (FAM36A) mutation Clinical and molecular characterization of neurodegenerative disorders Identification of a novel mutation in the coding region of the grey-lethal gene OSTM1 in human malignant infantile osteopetrosis = Identifizierung einer neuen Mutation in der kodierenden Region des "Grey-Lethal" Gens OSTM1 bei der humanen malignen infantilen Osteopetrose

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Alfredo Ramírez (1976-)

Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjects

Neuroinflammation in Alzheimer disease

X‐chromosome-wide association study for Alzheimer’s disease

Assessing blood-brain barrier dysfunction and its association with Alzheimer’s pathology, cognitive impairment and neuroinflammation

Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment

Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS

Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition

Dementia with Lewy bodies: old and new knowledge – Part 1: clinical aspects and diagnostics = Demenz mit Lewy-Körpern: alte und neue Erkenntnisse – Teil 1: Klinik und Diagnostik

Dementia with Lewy bodies: old and new knowledge—Part 2: treatment = Demenz mit Lewy-Körpern: alte und neue Erkenntnisse – Teil 2: Behandlung

Epigenome-wide analysis identifies methylome profiles linked to obsessive-compulsive disorder, disease severity, and treatment response

Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve

Epigenome-wide analysis identifies methylome profiles linked to obsessive-compulsive disorder, disease severity, and treatment response

Step by step: towards a better understanding of the genetic architecture of Alzheimer’s disease

Brain Health Services: Erfassung des individuellen Demenzrisikos am Kölner Alzheimer Präventionszentrum

Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2

Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment

Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study

Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Genome-wide meta-analyses reveal novel loci for verbal short-term memory and learning

Alzheimer’s Disease Plasma Biomarkers Distinguish Clinical Diagnostic Groups in Memory Clinic Patients

The mind's ratio : How the balance between ω-6 and ω-3 fatty acids affects the risk of late-life dementia

Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease

PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

Searching for the Holy Grail Will Need Biomarkers

A rare heterozygous TREM2 coding variant identified in familial clustering of dementia affects an intrinsically disordered protein region and function of TREM2

PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment

Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer’s disease-related dysregulation

Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood

Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

The BDNF Val66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease

Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer’s disease

Cognitive behavioural therapy for the treatment of late life depression : : study protocol of a multicentre, randomized, observer-blinded, controlled trial (CBTlate)

Genetik der Alzheimer-Krankheit

Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function

Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE)

Genetic estimators of DNA methylation provide insights into the molecular basis of polygenic traits

Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment

SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease

Novel genetic matching methods for handling population stratification in genome-wide association studies

Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration

Recessive dystonia-ataxia syndrome in a Turkish family caused by a COX20 (FAM36A) mutation

Clinical and molecular characterization of neurodegenerative disorders

Identification of a novel mutation in the coding region of the grey-lethal gene OSTM1 in human malignant infantile osteopetrosis = Identifizierung einer neuen Mutation in der kodierenden Region des "Grey-Lethal" Gens OSTM1 bei der humanen malignen infantilen Osteopetrose